CTLA-4 - CTLA-4

Parviz Azimnasab-Sorkhabi1, Maryam Soltani-Asl1, Musab Bouhajra2

  • 1Department of Surgery, School of Veterinary Medicine and Animal Sciences, University of Sao Paulo, Sao Paulo, Brazil; Pelotonia Institute for Immuno-Oncology and Division of Medical Oncology, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH, USA.

Immunology letters
|December 12, 2024
PubMed
概括

可溶性细胞毒性T淋巴细胞相关抗原4 (sCTLA-4) 可能阻碍抗CTLA-4癌症疗法. 这项研究探讨了sCTLA-4在瘤微环境 (TME) 中的抑制作用.